Cytoplasmic localization of PML particles in laminopathies

Histochemistry and Cell Biology

Volumn 139, Issue 1, 2013, Pages 119-134

  Houben, F ^a   De Vos, W H ^b   Krapels, I P C ^a   Coorens, M ^a   Kierkels, G J J ^a   Kamps, M A F ^a   Verstraeten, V L R M ^c   Marcelis, C L M ^d   Van Den Wijngaard, A ^a   Ramaekers, F C S ^a   Broers, J L V ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dermal fibroblasts; Immunofluorescence; Lamins; Nuclear rupture; PML nuclear bodies

Indexed keywords

BIOLOGICAL MARKER; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROBLAST; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; LAMINOPATHY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SCHOOL CHILD;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CELL NUCLEUS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; FIBROBLASTS; GENOTYPE; HUMANS; LAMIN TYPE A; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PHENOTYPE; SKIN; TIME FACTORS; TIME-LAPSE IMAGING; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84872317937     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-1005-5     Document Type: Article

References (50)

1. Bellodi C, Kindle K, Bernassola F, Dinsdale D, Cossarizza A, Melino G, Heery D, Salomoni P (2006) Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha. J Biol Chem 281(20):14465-14473 (Pubitemid 43848377)
2. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8(12):1006-1016 (Pubitemid 350174636)
3. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A (2002) Deconstructing PML-induced premature senescence. EMBO J 21:3358-3369 (Pubitemid 34760568)
4. Boisvert FM, K MJ, Box AK, Hendzel MJ, Bazett-Jones DP (2001) The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol 152:1099-1106 (Pubitemid 34286084)
5. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86(3):967-1008 (Pubitemid 44042881)
6. Butler JT, Hall LL, Smith KP, Lawrence JB (2009) Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells. J Cell Biochem 107:609-621
7. Carracedo A, Ito K, Pandolfi PP (2011) The nuclear bodies inside out: PML conquers the cytoplasm. Curr Opin Cell Biol 23(3):360-366
8. Cohen M, Lee KK, Wilson KL, Gruenbaum Y (2001) Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci 26(1):41-47 (Pubitemid 32124709)
9. de Noronha CM, Sherman MP, Lin HW, Cavrois MV, Moir RD, Goldman RD, Greene WC (2001) Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 294(5544):1105-1108 (Pubitemid 33041866)
10. De Vos WH, Houben F, Kamps M, Malhas A, Verheyen F, Cox J, Manders EM, Verstraeten VL, van Steensel MA, Marcelis CL, van den Wijngaard A, Vaux DJ, Ramaekers FCS, Broers JLV (2011) Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. Hum Mol Genet 20:4175-4186
11. Dellaire G, Ching RW, Ahmed K, Jalali F, Tse KC, Bristow RG, Bazett-Jones DP (2006) Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol 175:55-66 (Pubitemid 44537198)
12. Eskiw CH, Dellaire G, Bazett-Jones DP (2004) Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J Biol Chem 279:9577-9585 (Pubitemid 38296026)
13. Gheduzzi D, Boraldi F, Annovi G, DeVincenzi CP, Schurgers LJ, Vermeer C, Quaglino D, Ronchetti IP (2007) Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 87(10):998-1008 (Pubitemid 47429193)
14. Houben F, Willems CH, Declercq IL, Hochstenbach K, Kamps MA, Snoeckx LH, Ramaekers FC, Broers JL (2009) Disturbed nuclear orientation and cellular migration in A-type lamin deficient cells. Biochim Biophys Acta 1793(2):312-324
15. Ishov AM, Maul GG (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134:815-826 (Pubitemid 26278209)
16. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF III, Maul GG (1999) PML Is Critical for ND10 Formation and Recruits the PML-interacting Protein Daxx to this Nuclear Structure When Modified by SUMO-1. J Cell Biol 147(2):221-233 (Pubitemid 29496333)
17. Jul-Larsen A, Grudic A, Bjerkvig R, Boe SO (2009) Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins. J Cell Sci 122(Pt 8):1201-1210
18. Kamitani T, Kito K, Nguyen HP, Wada H, Fukada-Kamitami T, Yeh ET (1998) Identification of three major sentrinization sites in PML. J Biol Chem 273:26675-26682 (Pubitemid 28471682)
19. Kremers GJ, Goedhart J, van Munster EB, Gadella TW Jr (2006) Cyan and yellow super fluorescent proteins with improved brightness, protein folding, and FRET Forster radius. Biochemistry 45(21):6570-6580 (Pubitemid 43825357)
20. Lallemand-Breitenbach V, Zhu J, Puvion F (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193:1361-1371 (Pubitemid 32565965)
21. LaMorte VJ, Dyck JA, Ochs RL, Evans RM (1998) Localization of nascent RNA and CREB binding protein with the PMLcontaining nuclear body. Proc Natl Acad Sci USA 95:4991-4996 (Pubitemid 28208538)
22. Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, Piercy RJ, Messina S, Sewry C, Burke MM, McKenna W, Bonne G, Muntoni F (2005) Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve 31(5):602-609 (Pubitemid 40577783)
23. Muchir A, van Engelen BG, Lammens M, Mislow JM, McNally E, Schwartz K, Bonne G (2003) Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 291(2):352-362 (Pubitemid 37492866)
24. Muchir A, Medioni J, Laluc M, Massart C, Arimura T, van der Kooi AJ, Desguerre I, Mayer M, Ferrer X, Briault S, Hirano M, Worman HJ, Mallet A, Wehnert M, Schwartz K, Bonne G (2004) Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 30(4):444-450 (Pubitemid 39288147)
25. Muller S, Matunis MJ, Dejean A (1998) Conjugation with the ubiquitinrelated modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61-70 (Pubitemid 28041048)
26. Muntoni F, Bonne G, Goldfarb LG, Mercuri E, Piercy RJ, Burke M, Yaou RB, Richard P, Recan D, Shatunov A, Sewry CA, Brown SC (2006) Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain 129(Pt 5):1260-1268
27. Nagai S, Davoodi N, Gasser SM (2011) Nuclear organization in genome stability: SUMO connections. Cell Res 21:74-85
28. Rankin J, Auer-Grumbach M, Bagg W, Colclough K, Nguyen TD, Fenton-May J, Hattersley A, Hudson J, Jardine P, Josifova D, Longman C, McWilliam R, Owen K, Walker M, Wehnert M, Ellard S (2008) Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet A 146A(12):1530-1542 (Pubitemid 351792399)
29. Rasband WS (1997-2011) ImageJ v. 1.45. U. S. National Institutes of Health, Bethesda, Maryland, USA. http://imagej.nih.gov/ij/
30. Regad T, Chelbi-Alix MK (2001) Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20(49):7274-7286 (Pubitemid 33105016)
31. Savage DB, Soos MA, Powlson A, O'Rahilly S, McFarlane I, Halsall DJ, Barroso I, Thomas EL, Bell JD, Scobie I, Belchetz PE, Kelly WF, Schafer AJ (2004) Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 47(4):753-756 (Pubitemid 38658379)
32. Schirmer EC, Foisner R (2007) Proteins that associate with lamins: many faces, many functions. Exp Cell Res 313(10):2167-2179 (Pubitemid 46842977)
33. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311-322 (Pubitemid 30054364)
34. Seeler JS, Dejean A (1999) The PML nuclear bodies: Actors or extras? Curr Opin Genet Dev 9:362-367 (Pubitemid 29286478)
35. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24:331-339 (Pubitemid 44647906)
36. Sternsdorf T, Jensen K, Will H (1997) Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 139:1621-1634 (Pubitemid 28079228)
37. Stixova L, Matula P, Kozubek S, Gombitova A, Cmarko D, Raska I, Bartova E (2012) Trajectories and nuclear arrangement of PML bodies are influenced by A-type lamin deficiency. Biol Cell 104:418-432
38. Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan K-L, Tang ASL, Dyack S, Grzybowski J, Ruzyllo W, McBride H, Tesson F (2005) In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 42:639-647 (Pubitemid 41129036)
39. Van den Wijngaard A, Van Dijk W, Stassen AP, Lindsey PJ, Arens YH, Helderman P, Marcelis CL, Van der Smagt JJ, Heymans S, Volders PG, Jongbloed RJ, Smeets HJ (2009) CHIP-based sequence analysis of 34 cardiomyopathy genes reveals new genes Involved in HCM and DCM and multiple pathogenic mutations in single patients. Circulation 120:S565
40. Vargas JD, Hatch EM, Anderson DJ, Hetzer MW (2012) Transient nuclear envelope rupturing during interphase in human cancer cells. Nucleus 3(1):88-100
41. Verstraeten VL, Broers JL, van Steensel MA, Zinn-Justin S, Ramaekers FC, Steijlen PM, Kamps M, Kuijpers HJ, Merckx D, Smeets HJ, Hennekam RC, Marcelis CL, van den Wijngaard A (2006) Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 15(16):2509-2522 (Pubitemid 44288703)
42. Verstraeten VL, Caputo S, van Steensel MA, Duband-Goulet I, Zinn-Justin S, Kamps M, Kuijpers HJ, Ostlund C, Worman HJ, Briede JJ, Le Dour C, Marcelis CL, van Geel M, Steijlen PM, van den Wijngaard A, Ramaekers FC, Broers JL (2009) The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. J Cell Mol Med 13(5):959-971
43. Vlcek S, Foisner R (2007) A-type lamin networks in light of laminopathic diseases. Biochim Biophys Acta 1773(5):661-674 (Pubitemid 46660176)
44. Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS, Sheer D (2004) Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 164:515-526 (Pubitemid 38233313)
45. Wiesmeijer K, Molenaar C, Bekeer IM, Tanke HJ, Dirks RW (2002) Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J Struct Biol 140(1-3):180-188 (Pubitemid 36139859)
46. Wilson KL, Zastrow MS, Lee KK (2001) Lamins and disease: insights into nuclear infrastructure. Cell 104(5):647-650 (Pubitemid 32241015)
47. Wu WS, Vallian S, Seto E, Yang WM, Edmondson D, Roth S, Chang KS (2001) The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol 21:2259-2268 (Pubitemid 32222080)
48. Zhang YQ, Sarge KD (2008) Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies. J Cell Biol 182:35-39 (Pubitemid 352008619)
49. Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP (1999) A role for PML and the nuclear body in genomic stability. Oncogene 18:7941-7947 (Pubitemid 30050554)
50. Zhong S, Salomoni P, Pandolfi PP (2000) The transcriptional role of PML and the nuclear body. Nat Cell Biol 2:E85-E90